Cerebral venous sinus thrombosis (CVST) is Cerebral venous sinus thrombosis (CVST) is a rare and potentially deadly condition. Common etiologies include hypercoagulable diseases, low flow states ...

The spring of Molly Buccola's senior year at Santa Clara University, she ran the Los Angeles marathon. The next month, she ...

A blood clot in the veins that drain the blood from the brain is called a sinus or cerebral vein thrombosis. It is an uncommon type of clot, affecting about 1500 people in the United States per year.

Eli Lilly and Company today announced that data from studies of imlunestrant, an investigational oral selective estrogen receptor degrader (SERD), olomorasib, an investigational KRAS G12C inhibitor, ...

Berlin: Bayer has announced initiation of a Phase I clinical trial with BAY 3670549, an investigational highly selective ...

Bayer initiates phase I study with GIRK4 inhibitor for treatment of patients with atrial fibrillation: Berlin Thursday, May 22, 2025, 13:00 Hrs [IST] Bayer announced initiation of ...

According to Healthline and Cleveland Clinic, here are five brain diseases that have a high mortality rate: ...

Hebert, a pitcher and designated hitter for the Eagles, was seriously injured in April — the Thursday before Good Friday — ...

virginia.edu Background Cerebral venous sinus thrombosis (CVST) is an uncommon form of stroke that, when severe, can be a therapeutic challenge. Endovascular mechanical thrombectomy (EMT) techniques ...

A 42-year-old woman in the United Kingdom. The symptoms: During a reformer pilates class — a type of pilates that ...

However, its use in patients with cerebral venous sinus thrombosis-related CVSS has been less reported. Purpose To explore the safety and efficacy of stenting for patients with cerebral venous sinus ...

BAY 3670549 is an investigational highly selective G-protein-coupled inwardly rectifying potassium channel 4 (GIRK4) inhibitor with potential to help control ...